Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Channel One Style.
Press releases published on April 28, 2025

TeraWulf Announces Participation in Upcoming Investor and Industry Conferences
EASTON, Md., April 28, 2025 (GLOBE NEWSWIRE) -- TeraWulf Inc. (Nasdaq: WULF) (“TeraWulf” or the “Company”), which owns and operates vertically integrated, next-generation digital infrastructure primarily powered by zero-carbon energy, today announced that …

JPA Health Wins Med Comms Agency of the Year, Capping a Year of Transformative Growth
WASHINGTON, April 28, 2025 (GLOBE NEWSWIRE) -- JPA Health, a global, full-service, integrated health agency, has been named Med Comms Agency of the Year at the 2025 Manny Awards, hosted by MedAdNews in New York. Now in its 36th year, the Manny Awards …

Mobile Home Cash Offer Announces New ‘Sell Your Mobile Home Fast For Cash’ Service in Texas
Mabank, TX, April 28, 2025 (GLOBE NEWSWIRE) -- Mobile Home Cash Offer, a housing solutions and investment firm specializing in buying mobile homes, is happy to announce the launch of its ‘Sell Your Mobile Home Fast For Cash’ service in Texas. The new …

EY US unveils Jared Solomon of Five Iron Golf as an Entrepreneur Of The Year® 2025 New York Award finalist
New York, NY, April 28, 2025 (GLOBE NEWSWIRE) -- Ernst …

Getty Images and Ancestry Partner to Digitally Preserve Historic Archives of HBCUs
A Media Snippet accompanying this announcement is available by clicking on this link. NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- Getty Images (NYSE: GETY), a preeminent global visual content creator and marketplace, has announced a first-of-its-kind …

SELLAS Unveils Breakthrough Preclinical Data Highlighting Efficacy of SLS009 in TP53 Mutated AML at the 2025 AACR Conference
NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, …

Block Advisors by H&R Block Now Accepting Entries for Second Annual ‘Fund Her Future’ Grant Program Created to Help Female Founders Thrive, Fuel Small Business Growth
KANSAS CITY, Mo., April 28, 2025 (GLOBE NEWSWIRE) -- Block Advisors by H…

Evoke Pharma to Present New Data Comparing Tardive Dyskinesia Incidence in Continuous vs Intermittent Metoclopramide Use at DDW 2025
SOLANA BEACH, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) disorders with an emphasis on GIMOTI®, today announced that a new abstract …

One Stop Systems to Report First Quarter 2025 Financial Results
ESCONDIDO, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- One Stop Systems, Inc. (“OSS” or the “Company”) (Nasdaq: OSS), a leader in rugged Enterprise Class compute for artificial intelligence (AI), machine learning (ML) and sensor processing at the edge, …

Bel Fuse Announces Upcoming Investor Conference Schedule for May 2025
WEST ORANGE, N.J., April 28, 2025 (GLOBE NEWSWIRE) -- Bel Fuse Inc. (Nasdaq: BELFA and BELFB), a leading global manufacturer of products that power, protect and connect electronic circuits, today announced its investor conference schedule for May 2025: …

Hallador Energy Company Schedules First Quarter 2025 Conference Call for May 12, 2025 at 5:00 p.m. ET
TERRE HAUTE, Ind., April 28, 2025 (GLOBE NEWSWIRE) -- Hallador Energy Company (Nasdaq: HNRG) (“Hallador” or the “Company”), will host a conference call on Monday, May 12, 2025, at 5:00 p.m. Eastern time to discuss its financial results for the first …

Workhorse W56 EV Step Van Completes 2,400-Mile Cross-Country Drive to ACT Expo, Demonstrating Real-World Performance and Efficiency
CINCINNATI, April 28, 2025 (GLOBE NEWSWIRE) -- Workhorse Group Inc. (Nasdaq: WKHS) (“Workhorse” or “the Company”), an American technology company focused on pioneering the transition to zero-emission commercial vehicles, today announced the successful …

Brag House, Florida Gators Athletics, and Learfield Announce Strategic Partnership to Create New Digital Sports Medium for Gen Z
NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- Brag House Holdings, Inc. (NASDAQ: TBH) (the “Company” or “Brag House”), the premier Gen Z engagement platform at the intersection of gaming, college sports, and social interaction, today announced a strategic …

Uncovering Common Issues in Modern Salt Rooms - Insights from a True Pioneer
Dr. Margaret Smiechowski’s New Guide Exposes What’s Missing in Today’s Trendy Salt Rooms RUTLAND, VT, UNITED STATES, April 27, 2025 /EINPresswire.com/ -- Dr. Margaret Smiechowski, widely regarded as the leading authority on salt therapy in North America …

Point of Care Diagnostics Market Size to Reach $82.95 Bn by 2028 Globally, at 12.7% CAGR: The Insight Partners
US …

Aboriginal Cultural Immersions - Misconceptions of Indigenous Welcome To Country
Learn and Understand Aboriginal Culture during Reconciliation Week, NAIDOC Week and beyond. MELBOURNE, VICTORIA, AUSTRALIA, April 28, 2025 /EINPresswire.com/ -- Aboriginal and Torres Strait Islander cultural ceremonies, including smoking ceremonies, …

NobleAI to Present at 2025 AOCS Annual Meeting
PORTLAND, Ore., April 28, 2025 (GLOBE NEWSWIRE) -- NobleAI, the leader in practical AI solutions for innovation in the chemicals and energy industries, today announced that it will present with ExxonMobil at the upcoming American Oil Chemists' Society ( …

Endpoint Detection and Response (EDR) Market Size to Reach $22.00 Bn by 2031 Globally, at 25.9% CAGR: The Insight Partners
US …

FOX Sports CEO Eric Shanks and Baseball Legend Alex Rodriguez Named Co-Chairs of Boys & Girls Clubs of America’s 2025 National Youth of the Year Celebration
ATLANTA, April 28, 2025 (GLOBE NEWSWIRE) -- Boys …

Compass Therapeutics Presents Data on Enhanced Efficacy of CTX-471 in Combination with Tovecimig in Checkpoint-Refractory Models at the American Association for Cancer Research (AACR) Annual Meeting
CTX-471 monotherapy demonstrated efficacy in multiple murine models, including models highly resistant to immune checkpoint inhibitors. Combining CTX-471 with tovecimig (CTX-009) markedly increased anti-tumor efficacy in these models. Tovecimig in …